Ana Beatriz Depaula-Silva

Dr. Ana Beatriz Depaula-Silva

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2019 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
ADAna Beatriz Depaula-Silva
Ana Beatriz Depaula-Silva
CGCarlos Gorbea
Carlos Gorbea
DDDaniel J. Doty
Daniel J. Doty
JLJane E. Libbey
Jane E. Libbey
JSJohn Michael S. Sanchez
John Michael S. Sanchez
RFRobert S. Fujinami
Robert S. Fujinami
In the healthy central nervous system (CNS), microglia are found in a homeostatic state and peripheral macrophages are absent from the brain. Microglia play key roles in maintaining CNS homeostasis and acting as first responders to infection and inflammation, and peripheral macrophages infiltrate the CNS during neuroinflammation. Due to their distinct origins and functions, discrimination between these cell populations is essential to the comprehension of neuroinflammatory disorders. Studies comparing the gene profiles of microglia and peripheral macrophages, or macrophages in vitro-derived from bone marrow, under non-infectious conditions of the CNS, have revealed valuable microglial-specific genes. However, studies comparing gene profiles between CNS-infiltrating macrophages and microglia, when both are isolated from the CNS during viral-induced neuroinflammation, are lacking. We isolated, via flow cytometry, microglia and infiltrating macrophages from the brains of Theiler’s murine encephalomyelitis virus-infected C57BL/6 J mice and used RNA-Seq, followed by validation with qPCR, to examine the differential transcriptional profiles of these cells. We utilized primary literature defining subcellular localization to determine whether or not particular proteins extracted from the transcriptional profiles were expressed at the cell surface. The surface expression and cellular specificity of triggering receptor expressed on myeloid cells 1 (TREM-1) protein were examined via flow cytometry. We also examined the immune response gene profile within the transcriptional profiles of these isolated microglia and infiltrating macrophages. We have identified and validated new microglial- and macrophage-specific genes, encoding cell surface proteins, expressed at the peak of neuroinflammation. TREM-1 protein was confirmed to be expressed by infiltrating macrophages, not microglia, at the peak of neuroinflammation. We also identified both unique and redundant immune functions, through examination of the immune response gene profiles, of microglia and infiltrating macrophages during neurotropic viral infection. The differential expression of cell surface-specific genes during neuroinflammation can potentially be used to discriminate between microglia and macrophages as well as provide a resource that can be further utilized to target and manipulate specific cell responses during neuroinflammation.

1 July 2017 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
ADAna Beatriz Depaula-Silva
Ana Beatriz Depaula-Silva
THTyler J. Hanak
Tyler J. Hanak
JLJane E. Libbey
Jane E. Libbey
RFRobert S. Fujinami
Robert S. Fujinami

1 February 2016 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
Laura J MartinsLaura J Martins
Laura J Martins
PBPawel Bonczkowski
Pawel Bonczkowski
ASAdam M. Spivak
Adam M. Spivak
WSWard De Spiegelaere
Ward De Spiegelaere
CNCamille L. Novis
Camille L. Novis
VPVicente Planelles
Vicente Planelles
HIV-1 latently infected cells in vivo can be found in extremely low frequencies. Therefore, in vitro cell culture models have been used extensively for the study of HIV-1 latency. Often, these in vitro systems utilize defective viruses. Defective viruses allow for synchronized infections and circumvent the use of antiretrovirals. In addition, replication-defective viruses cause minimal cytopathicity because they fail to spread and usually do not encode env or accessory genes. On the other hand, replication-competent viruses encode all or most viral genes and better recapitulate the nuances of the viral replication cycle. The study of latency with replication-competent viruses requires the use of antiretroviral drugs in culture, and this mirrors the use of antiretroviral treatment (ART) in vivo. We describe a model that utilizes cultured central memory CD4+ T cells and replication-competent HIV-1. This method generates latently infected cells that can be reactivated using latency reversing agents in the presence of antiretroviral drugs. We also describe a method for the removal of productively infected cells prior to viral reactivation, which takes advantage of the downregulation of CD4 by HIV-1, and the use of a GFP-encoding virus for increased throughput.

1 June 2014 in Cell Reports
Verified
Journal Article
Open access
PRPeter Ramirez
Peter Ramirez
MFMarylinda Famiglietti
Marylinda Famiglietti
BSBharatwaj Sowrirajan
Bharatwaj Sowrirajan
ADAna Beatriz Depaula-Silva
Ana Beatriz Depaula-Silva
CRChristopher Rodesch
Christopher Rodesch
VPVicente Planelles
Vicente Planelles
The chemokine receptor CCR7 plays a crucial role in the homing of central memory and naive T cells to peripheral lymphoid organs. Here, we show that the HIV-1 accessory protein Vpu downregulates CCR7 on the surface of CD4(+) T cells. Vpu and CCR7 were found to specifically interact and colocalize within the trans-Golgi network, where CCR7 is retained. Downmodulation of CCR7 did not involve degradation or endocytosis and was strictly dependent on Vpu expression. Stimulation of HIV-1-infected primary CD4(+) T cells with the CCR7 ligand CCL19 resulted in reduced mobilization of Ca(2+), reduced phosphorylation of Erk1/2, and impaired migration toward CCL19. Specific amino acid residues within the transmembrane domain of Vpu that were previously shown to be critical for BST-2 downmodulation (A14, A18, and W22) were also necessary for CCR7 downregulation. These results suggest that BST-2 and CCR7 may be downregulated via similar mechanisms.

11 March 2019 in Journal of NeuroVirology
Verified
Journal Article
Closed access
PDF file
JSJohn Michael S. Sanchez
John Michael S. Sanchez
ADAna Beatriz Depaula-Silva
Ana Beatriz Depaula-Silva
DDDaniel J. Doty
Daniel J. Doty
ATAmanda Truong
Amanda Truong
JLJane E. Libbey
Jane E. Libbey
RFRobert S. Fujinami
Robert S. Fujinami

7 March 2020 in Clinical Immunology
Verified
Journal Article
Closed access
JSJohn Michael S. Sanchez
John Michael S. Sanchez
ADAna Beatriz Depaula-Silva
Ana Beatriz Depaula-Silva
JLJane E. Libbey
Jane E. Libbey
RFRobert S. Fujinami
Robert S. Fujinami